Evidence for an increased catecholamine synthesis in rat adrenal glands following stimulation of peripheral dopamine receptors
Summary
In studies on peripheral dopamine (DA) turnover in our department evidence has accumulated that changes in adrenal DA levels induced by varying degrees of neurogenic stimulation roughly reflect changes in the catecholamine (CA) synthesis rate. The question arises if changes in DA levels in rat adrenals induced by different DA D-2 receptor agonists and previously reported from our laboratory, also indicate changes in CA synthesis. After various periods of drug administration rats were killed by decapitation and tissue CA levels in adrenals and forebrain were determined by HPLC-EC. The potent inhibitor of DA-β-hydroxylase FLA 63 (40 mg/kg i.p.) increased adrenal DA by 186% after 1 h and by 423% after 3 h. The DA D-2 agonist quinpirole (0.2 mg/kg s.c, 30 min) itself increased adrenal DA by 55–60% compared to control. In FLA 63 pretreated rats quinpirole increased adrenal DA levels by further 127% (FLA 63 — 1 h), resp. 122% (FLA 63 — 3h) than did FLA 63 itself. The DA D-2 receptor antagonist domperidone (3 mg/kg s.c, 150 min) blocked the quinpirole effect both in saline and FLA 63 (3 h) pretreated rats. Adrenal DOP AC was changed in similar manner as adrenal DA in FLA 63 pretreated rats. No significant changes either in adrenal NA or A were observed after FLA 63 pretreatment.
Under the present experimental conditions adreanal DA may thus mainly be looked upon as an intermediate in the synthesis of NA and A, and the elevation of DA induced by DA D-2 receptor stimulation as a consequence of increased catecholamine synthesis.
Keywords
Dopamine dopamine receptors catecholamines — synthesis dopamine-β-hydroxylase adrenal medulla ratPreview
Unable to display preview. Download preview PDF.
References
- Almgren O, Carlsson A, Snider S (1979) Tissue dopamine levels as an indicator of tyrosine hydroxylase activity. In: Imbs JL, Schwartz J (eds) Peripheral dopaminergic receptors. Pergamon Press, New York, pp 29–40Google Scholar
- Bigornia L, Allen CN, Jan C-R, Lyon RA, Titeler M, Schneider AS (1990) D2 dopamine receptors modulate calcium channel currents and catecholamine secretion in bovine adrenal chromaffin cells. J Pharmacol Exp Ther 252: 586–592Google Scholar
- Carlsson A, Lindqvist M (1974) Studies on the neurogenic short-term control of adreno-medullary hormone synthesis. J Neural Transm 35: 181–196Google Scholar
- Carlsson A, Snider SR, Almgren O, Lindqvist M (1973) The neurogenic short-term control of catecholamine synthesis and release in the sympatho-adrenal system, as reflected in the levels of endogenous dopamine and β-hydroxylated catecholamines. In: Usdin E, Snyder S (eds) Frontiers in catecholamine research. Pergamon Press, New York, pp 551–556 (Proceedings of the Third International Catecholamine Symposium, Strasbourg)Google Scholar
- Corrodi H, Fuxe K, Hamberger B, Ljungdahl Å (1970) Studies on central and peripheral noradrenaline neurons using a new dopamine-β-hydroxylase inhibitor. Eur J Pharmacol 12: 145–155Google Scholar
- Gonzalez MC, Artalejo AR, Montiel C, Hervas PP, Garcia AG (1986) Characterization of a dopaminergic receptor that modulates adrenomedullary catecholamine release. J Neurochem 47: 382–388Google Scholar
- Kujacic M, Carlsson A (1993) Acute effects of dopamine receptor agonists and antagonists on adrenaline release from the adrenal medulla in rats (in press)Google Scholar
- Kujacic M, Svensson K, Löfberg L, Carlsson A (1990) Acute changes in dopamine levels in rat adrenal glands after administration of dopamine receptor agonists and antagonists. Eur J Pharmacol 177: 163–170Google Scholar
- Kujacic M, Svensson K, Löfberg L, Carlsson A (1991) Dopamine receptors, controlling dopamine levels in rat adrenal glands — comparison with central dopaminergic auto-receptors. J Neural Transm [GenSect] 84: 195–209Google Scholar
- Lyon RA, Titeler M, Bigornia L, Schneider AS (1987) D 2 dopamine receptors on bovine chromaffin cell membranes: identification and characterization by (3 H)N-methylspiperone binding. J Neurochem 48: 631–635Google Scholar
- Milliken GA, Johnson DE (1984) Analysis of messy data, vol 1. Designed experiments Lifetime Learning Publications, Belmont, California, p 33Google Scholar
- Quik M, Bergeron L, Mount H, Philie J (1987) Dopamine D 2 receptor binding in adrenal medulla: characterization using (3 H)spiperone. Biochem Pharmacol 36: 3707–3713Google Scholar
- Schalling M, Dagerlind Å, Goldstein M, Ehrlich M, Greengard P, Hökfelt T (1990) Comparison of gene expression of the dopamine D 2 receptor and DARPP-32 in rat brain, pituitary and adrenal gland. Eur J Pharmacol Mol Pharmacol Sect 188: 277–281Google Scholar
- Snider SR, Carlsson A (1972) The adrenal dopamine as an indicator of adrenomedullary hormone biosynthesis. Naunyn Schmiedebergs Arch Pharmacol 275: 347–357Google Scholar
- Svensson T, Waldeck B (1969) On the significance of central noradrenaline for motor activity: experiments with a new dopamine \-hydroxylase inhibitor. Eur J Pharmacol 7: 278–282Google Scholar